Ottawa Looks at Wastewater to Track Drug Use Trends
Ottawa city council has taken a step toward using the city's wastewater system as a public health tool, voting to forward a proposal on drug-related wastewater testing to the Ottawa Board of Health for further study.
The motion directs the water services department and Ottawa Public Health to examine the feasibility of identifying key geographic locations across the city where wastewater samples could be collected and analyzed for traces of drug use — a practice known as wastewater-based epidemiology (WBE).
What Is Wastewater-Based Epidemiology?
Wastewater testing for public health purposes is not new — Ottawa and many other Canadian cities used it extensively during the COVID-19 pandemic to detect and track virus levels in communities, sometimes even before clinical cases appeared.
The same principle applies to drugs. When people consume substances — whether illicit drugs like fentanyl and methamphetamine, or even prescription medications — metabolites and traces of those substances pass through the body and end up in the sewer system. Analyzing those samples gives public health officials a real-time, population-level picture of drug consumption patterns in specific neighbourhoods.
Because wastewater data is anonymous and aggregate, it sidesteps some of the barriers that make individual-level drug use data hard to collect — stigma, fear of prosecution, and underreporting among them.
Why Ottawa Is Exploring This Now
The proposal comes as Ottawa, like cities across Canada, continues to grapple with an ongoing overdose and opioid crisis. Fentanyl and its analogues have driven a sharp rise in drug-related deaths in the capital over the past several years, and public health officials have consistently flagged the need for better, faster data to guide harm reduction responses.
Wastewater surveillance could give Ottawa Public Health an early warning system — flagging spikes in certain substances in specific parts of the city before they show up in emergency department visits or mortality statistics. That kind of lead time could be critical for deploying mobile harm reduction services, alerting community organizations, or adjusting naloxone distribution.
What Comes Next
With the referral approved, the ball is now in Ottawa Public Health's court. Staff will report back to the Board of Health on the feasibility of the program, including which neighbourhoods or catchment zones would yield the most useful data, what the sampling and analysis would cost, and how findings would be communicated publicly.
Several Canadian cities, including Toronto and Vancouver, have already established ongoing drug wastewater monitoring programs, so Ottawa would not be starting from scratch. There are established methodologies and lab partnerships that could help accelerate implementation if the Board of Health recommends moving forward.
For residents, the initiative represents a shift toward evidence-based harm reduction — using the city's own infrastructure to better understand and respond to one of its most pressing public health challenges.
Source: Ottawa Citizen
